MX2007005348A - Formas amorfas y polimorficas de sodio de telmisartan. - Google Patents
Formas amorfas y polimorficas de sodio de telmisartan.Info
- Publication number
- MX2007005348A MX2007005348A MX2007005348A MX2007005348A MX2007005348A MX 2007005348 A MX2007005348 A MX 2007005348A MX 2007005348 A MX2007005348 A MX 2007005348A MX 2007005348 A MX2007005348 A MX 2007005348A MX 2007005348 A MX2007005348 A MX 2007005348A
- Authority
- MX
- Mexico
- Prior art keywords
- amorphous
- telmisartan sodium
- polymorphic forms
- telmisartan
- sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se proporciona la forma amorfa de sodio de telmisartan y la preparacion de ella. Tambien se proporcionan las formas 0 a XIII y XV a XX cristalinas polimorfas de sodio de telmisartan y las preparaciones de ellas. Tambien se proporcionan composiciones farmaceuticas de las formas amorfas y polimorficas de sodio de telmisartan o mezclas de ellas, y metodos de tratamiento de un mamifero que lo necesita.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62484204P | 2004-11-03 | 2004-11-03 | |
US65224605P | 2005-02-11 | 2005-02-11 | |
PCT/US2005/040059 WO2006050509A2 (en) | 2004-11-03 | 2005-11-03 | Amorphous and polymorphic forms of telmisartan sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007005348A true MX2007005348A (es) | 2007-06-25 |
Family
ID=35788339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007005348A MX2007005348A (es) | 2004-11-03 | 2005-11-03 | Formas amorfas y polimorficas de sodio de telmisartan. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060293377A1 (es) |
EP (1) | EP1807400A2 (es) |
JP (1) | JP2008516001A (es) |
KR (1) | KR20070072588A (es) |
CA (1) | CA2583694A1 (es) |
IL (1) | IL182240A0 (es) |
MX (1) | MX2007005348A (es) |
WO (1) | WO2006050509A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006044648A1 (en) | 2004-10-15 | 2006-04-27 | Teva Pharmaceutical Industries Ltd. | Process for preparing telmisartan |
US20090030057A1 (en) * | 2005-11-22 | 2009-01-29 | Shlomit Wizel | Pharmaceutical composition of telmisartan |
SI22297A (sl) * | 2006-06-23 | 2007-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Priprava soli telmisartana |
CN101990434B (zh) * | 2008-01-15 | 2013-07-31 | 西佳技术公司 | 用于治疗沙粒病毒感染的抗病毒药物 |
ES2415357T3 (es) | 2009-06-19 | 2013-07-25 | Krka Tovarna Zdravil, D.D., Novo Mesto | Procedimiento para la preparación de telmisartán |
EA025946B1 (ru) | 2010-10-27 | 2017-02-28 | Крка, Товарна Здравил, Д. Д., Ново Место | Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин |
MX2021001169A (es) | 2013-11-15 | 2023-02-10 | Akebia Therapeutics Inc | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. |
EP2979691A1 (en) * | 2014-07-30 | 2016-02-03 | Boehringer Ingelheim International GmbH | Oral disintegrating tablet |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591762A (en) * | 1991-02-06 | 1997-01-07 | Dr. Karl Thomae Gmbh | Benzimidazoles useful as angiotensin-11 antagonists |
US6358986B1 (en) * | 1999-01-19 | 2002-03-19 | Boehringer Ingelheim Pharma Kg | Polymorphs of telmisartan |
DE10153737A1 (de) * | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
US6737432B2 (en) * | 2001-10-31 | 2004-05-18 | Boehringer Ingelheim Pharma Kg | Crystalline form of telmisartan sodium |
CN101352421A (zh) * | 2002-01-16 | 2009-01-28 | 贝林格尔英格海姆法玛两合公司 | 一种制备基本上非结晶形式的替米沙坦的方法 |
US6770762B2 (en) * | 2002-01-18 | 2004-08-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole |
GB0214224D0 (en) * | 2002-06-20 | 2002-07-31 | Strover Angus E | Unicompartmental prosthetic knee joint device |
DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
US8980870B2 (en) * | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
US9029363B2 (en) * | 2003-04-30 | 2015-05-12 | Boehringer Ingelheim International Gmbh | Telmisartan sodium salt pharmaceutical formulation |
CN1548421A (zh) * | 2003-05-22 | 2004-11-24 | 上海医药工业研究院 | 替米沙坦盐及其制备方法 |
ATE458476T1 (de) * | 2004-06-01 | 2010-03-15 | Teva Gyogyszergyar Zartkoeruen | Verfahren für die zubereitung der amorphen form eines medikamentes |
-
2005
- 2005-11-03 WO PCT/US2005/040059 patent/WO2006050509A2/en active Application Filing
- 2005-11-03 MX MX2007005348A patent/MX2007005348A/es unknown
- 2005-11-03 EP EP05817424A patent/EP1807400A2/en not_active Withdrawn
- 2005-11-03 US US11/267,520 patent/US20060293377A1/en not_active Abandoned
- 2005-11-03 JP JP2007537047A patent/JP2008516001A/ja active Pending
- 2005-11-03 CA CA002583694A patent/CA2583694A1/en not_active Abandoned
- 2005-11-03 KR KR1020077011120A patent/KR20070072588A/ko not_active Application Discontinuation
-
2007
- 2007-03-27 IL IL182240A patent/IL182240A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2583694A1 (en) | 2006-05-11 |
IL182240A0 (en) | 2007-09-20 |
WO2006050509A3 (en) | 2006-08-03 |
KR20070072588A (ko) | 2007-07-04 |
US20060293377A1 (en) | 2006-12-28 |
WO2006050509A2 (en) | 2006-05-11 |
JP2008516001A (ja) | 2008-05-15 |
EP1807400A2 (en) | 2007-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007005348A (es) | Formas amorfas y polimorficas de sodio de telmisartan. | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
NO20090328L (no) | Nye forbindelser 385 | |
BRPI0519124A2 (pt) | composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço | |
TW200608972A (en) | Aryl-pyridine derivatives | |
MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
NO20076039L (no) | TRPV1-agonistforbindelser og fremgangsmater for fremstilling og anvendelse av disse | |
EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
NO20062098L (no) | Faststofftilstandmontelukast | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
MXPA06000921A (es) | Derivados de benzamidazoles como inhibidores de mek. | |
TW200736223A (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
NO20090327L (no) | Nye forbindelser 384 | |
ATE384058T1 (de) | Thiazolderivate | |
WO2007046867A3 (en) | Piperidine derivatives and their uses as therapeutic agents | |
EA200501645A1 (ru) | Ингибиторы гликогенфосфорилазы, представляющие собой амиды пирролопиридин-2-карбоновых кислот | |
NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
PT1828177E (pt) | Novos antagonistas dos receptores da mch | |
BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
NO20050573L (no) | 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler | |
ATE424821T1 (de) | Pyrrolopyridin-2-karbonsäureamide |